Sanofi Ventures
Corporate venture capital
RollingLast verified 10 Nov 2026
Sanofi Ventures is the corporate venture capital fund of Sanofi, investing in early-stage biotech and digital health companies from seed to Series B and beyond.
3 deals in the last 24 months, latest 5 Nov 2026. From its website and its deals in the news.
Key facts
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Biotech & pharma, Healthtech
- Typical round size
- €118.5M (median of its recent deals, not a ticket)
- Leads rounds
- 33% of recent deals with a known role
- Eligible countries
- Not stated
- Provider based in
- France
- Timing
- Rolling applications
- Focus
- biotech; digital health; transformational science and technology; improving human health
- How to apply
- Apply route unknown
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| T-Therapeutics | Series B | Biotech & pharma, Healthtech | €118.5M | participant | 5 Nov 2026 |
| OMass Therapeutics | Series C+ | Biotech & pharma | €275.7M | participant | 15 Oct 2026 |
| Granite Bio | Series B | Biotech & pharma | €62.7M | lead | 24 Apr 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing in early-stage transformational science and technology
https://www.sanofiventures.com/ - Sectors
We invest in top-tier biotech and digital health companies that focus on helping patients and transforming the practice of medicine.
https://www.sanofiventures.com/ - Stages
We invest across all stages of the private company lifecycle, from Seed to Series B and beyond
https://www.sanofiventures.com/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Sanofi Ventures? Claim this profile to confirm what you invest in.